** AdAlta 1AD.AX soars 33.3% to A$0.012, highest since March 4
** Stock set for biggest intraday gain since March 6, 2024
** Biotechnology firm says SYNthesis BioVentures (SYNBV) to invest up to A$2 mln ($1.3 mln) in seed financing in co's special purpose subsidiary AdCella
** Adds SYNBV has the right to invest another A$5.5 mln in Series A funding round for AdCella on top of its seed financing
** 1AD sheds 25% YTD
($1 = A$1.5780)
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。